Form D · Biotechnology
California Cultured Inc.
West Sacramento, CA · CIK 0002024675
Offering snapshot reported Feb 10, 2026 · SEC filing
- Reported sold
- $8.07M Offering amount: $8.07M
- Investors reported
- 35 Form D · investor count
- Minimum accepted
- $45K Reported outside-investor minimum
- First sale
- Mar 26, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors12 → 35
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 10, 2026 | Initial | $8,065,000 | No comparison | 12 | SEC filing |
| Feb 10, 2026 | Initial | $7,510,059 | No comparison | 30 | SEC filing |
| Feb 10, 2026 | Amendment | $8,065,000 | $0vs Feb 10, 2026 | 35 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-573050
Source: Form D, filed Feb 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Debbie Neumann | Director, Executive |
| Alan Perlstein | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3650 Industrial Blvd. Ste 100
West Sacramento, CA, 95691
West Sacramento, CA, 95691